Medical Device | May 08, 2026
Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Enabling a new era in minimally invasive obesity treatment across Europe
Healthcare is timely and personal – and its delivery should be too
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
Subscribe To Our Newsletter & Stay Updated
